Rich Pharmaceuticals, Inc. Convertible Notes Payable, Current
Rich Pharmaceuticals, Inc. had Convertible Notes Payable, Current of $815.04 thousand as of 2018-03-31, per its 10-K filed 2018-07-17.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2018-07-17
- 2018-03-31: Convertible Notes Payable, Current $815.04K.
- 2017-12-31: Convertible Notes Payable, Current $838.51K.
- 2017-09-30: Convertible Notes Payable, Current $688.98K.
- 2017-06-30: Convertible Notes Payable, Current $402.77K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2018-03-31 | $815.04K 10-K · filed 2018-07-17 | |
| 2017-12-31 | $838.51K 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $688.98K 10-Q · filed 2017-12-29 | |
| 2017-06-30 | $402.77K 10-Q · filed 2017-12-06 | |
| 2017-03-31 | $514.08K 10-K · filed 2018-07-17 | |
| 2016-12-31 | $376.30K 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $437.43K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $371.64K 10-Q · filed 2016-08-22 | |
| 2016-03-31 | $201.88K 10-K · filed 2017-09-05 | |
| 2015-12-31 | $193.19K 10-Q · filed 2016-02-22 | |
| 2015-09-30 | $183.36K 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $254.41K 10-Q · filed 2015-09-25 | |
| 2015-03-31 | $402.13K 10-K · filed 2016-08-22 | |
| 2014-12-31 | $325.07K 10-Q · filed 2015-02-25 | |
| 2014-09-30 | $277.60K 10-Q · filed 2014-11-19 | |
| 2014-03-31 | $402.13K 10-Q · filed 2015-09-25 | $37.50K 10-Q · filed 2014-11-19 |